Literature DB >> 10765398

Superior vena cava stenting.

C D Yim1, S S Sane, H Bjarnason.   

Abstract

Treatment of SVC obstruction with metallic stents is a rewarding procedure. The patients have symptoms that are severe and debilitating and cause significant impairment of life-style. Stent placement rapidly alleviates the symptoms of SVC syndrome and improves the patient's quality of life. The long-term patency rates have not been established; however, in patients with SVC syndrome secondary to malignant disease, stents usually remain patent for the lifetime of the patient. Recurrences can be treated with further interventional radiographic techniques. Currently, because the long-term patency rates of SVC stents are not known, most interventional radiologists tend to treat SVC stenosis from benign causes with balloon angioplasty before placing metallic stents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10765398     DOI: 10.1016/s0033-8389(05)70171-8

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  10 in total

Review 1.  Palliative procedures in lung cancer.

Authors:  Emi Masuda; Akhilesh K Sista; Bradley B Pua; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

2.  Superior vena cava syndrome due to metastasis from acinic cell carcinoma of the parotid gland.

Authors:  Hamid Shaaban; Tejas Modi; Hiren Patel; Abhishek Kumar; Michael Maroules
Journal:  Lung India       Date:  2015 Jan-Feb

3.  Neurologic and ophthalmologic complications of vascular access in a hemodialysis patient.

Authors:  Roxana Cleper; Nitza Goldenberg-Cohen; Liora Kornreich; Irit Krause; Miriam Davidovits
Journal:  Pediatr Nephrol       Date:  2007-05-09       Impact factor: 3.714

Review 4.  Identifying oncological emergencies.

Authors:  Achuta K Guddati; Nilay Kumar; Ankur Segon; Parijat S Joy; Creticus P Marak; Gagan Kumar
Journal:  Med Oncol       Date:  2013-07-20       Impact factor: 3.064

5.  Massive thrombosis of brachiocephalic veins and superior vena cava syndrome in a patient with non-small cell lung cancer treated with the epidermal growth factor receptor inhibitor erlotinib.

Authors:  Raffaella Salmi; Piergiorgio Gaudenzi; Filippo Di Todaro; Pierluigi Morandi; Ingrid Nielsen; Roberto Manfredini
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

6.  Malignant thrombosis of the superior vena cava caused by non-small-cell lung cancer treated with radiation and erlotinib: a case with complete and prolonged response over 3 years.

Authors:  Jianyang Wang; Jun Liang; Wenqing Wang; Han Ouyang; Luhua Wang
Journal:  Onco Targets Ther       Date:  2013-07-01       Impact factor: 4.147

7.  Superior Vena Cava (SVC) Endovascular Reconstruction with Implanted Central Venous Catheter Repositioning for Treatment of Malignant SVC Obstruction.

Authors:  Stephanie Volpi; Francesco Doenz; Salah D Qanadli
Journal:  Front Surg       Date:  2018-01-26

8.  Superior vena cava syndrome: endovascular management.

Authors:  Walter Kegham Karakhanian; Walter Zavem Karakhanian; Sergio Quilici Belczak
Journal:  J Vasc Bras       Date:  2019-09-24

9.  Iatrogenic occlusion of bilateral jugular veins, subclavian vein, and superior vena cava after repeated jugular cannulation associated with Arnold-Chiari malformation: Successful endovascular treatment.

Authors:  Przemyslaw Nowakowski; Piotr Buszman; Stefan Kiesz; Pawel Buszman
Journal:  J Vasc Surg Cases Innov Tech       Date:  2020-02-04

10.  Role of CT venography in the diagnosis and treatment of benign thoracic central venous obstruction.

Authors:  Hyo- Cheol Kim; Jin Wook Chung; Jae Hyung Park; Yong Hu Yin; Seong Ho Park; Chang Jin Yoon; Young Ho Choi
Journal:  Korean J Radiol       Date:  2003 Jul-Sep       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.